Answers are grounded in this paper and cite their sources.
Analysis shows microsite and canopy affect undergrowth height and mortality rate in old-growth forests.
We analysed the height-age structure of spruce ( (L.) H. Karst) undergrowth in three forest canopy areas (canopy gap; crown edge; canopy) and five microsite types (undisturbed forest litter; microelevations unrelated to xylolytic substrate (XS); microelevations formed by XS; microhabitats generated by visually indiscernible, “hidden” part of XS; XS impact zone) in three old-growth middle taiga spruce forests. The undergrowth reaches the height of 50 cm at the age of 19-24 years. The forest growth conditions, canopy and microsite influence the young trees that are taller than 50 cm. The undergrowth reaches the height of 100 cm at the age of 28-36 years, 150 cm - at 31-39 years. An exponential model best describes the changes in the undergrowth abundance with age. In five microsite types, 18-26% of the undergrowth reaches the height category of 51-100 cm (compared to the amount of small (< 50 cm) undergrowth). As for the height category of 101-150 cm, it’s reached by only about 6-8% of young trees in the bilberry spruce forest, 10-23% - in the oxalis-bilberry spruce forest with and , and 5-25% - in the oxalis-bilberry spruce forest with the co-dominance of . Only 3% of the undergrowth from the microsites formed by the XS in the bilberry spruce forest reaches the height category of 151-200 cm. In the spruce stand with the participation of deciduous species in all microsite types (except the “hidden” parts of XS), only 6% of the P. abies undergrowth reaches this height category. Similarly, in the pine-spruce stand, 6% of the undergrowth reaches this height category, but only on microelevations formed by XS and in the XS impact zone. The results indicate that the mortality rate of the understory with a height more than 50 cm is generally comparable in all microsite types (including those formed by XS).
No takes yet. Share an insight, caveat, or question.
A.V. Kireeva (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: